Add like
Add dislike
Add to saved papers

HIV medical care interruption among people living with HIV in Spain, 2004-2020.

AIDS 2023 March 22
OBJECTIVE: We estimated the incidence rate of HIV medical care interruption (MCI) and its evolution over a 16 year-period, and identified associated risk factors among HIV-positive individuals from the CoRIS cohort in 2004-2020.

DESIGN: We included antiretroviral-naive individuals aged≥18 years at enrolment, recruited between January 1, 2004, and August 30, 2019, and followed-up until November 30, 2020.

METHODS: Individuals with any time interval >15 months between two visits were defined as having a MCI. We calculated the incidence rate (IR) of having at least one MCI and used multivariable Poisson regression models to identify associated risk factors.

RESULTS: Of 15,274 individuals, 5,481 (35.9%) had at least one MCI. Of those, 2,536 (46.3%) returned to HIV care after MCI and 3,753 (68.5%) were lost to follow-up at the end of the study period. The incidence rate (IR) of MCI was 7.2/100 person-years (95%CI: 7.0-7.4)]. The annual IR gradually decreased from 20.5/100 py (95%CI: 16.4-25.6) in 2004 to 4.9/100 py (95%CI: 4.4-5.5) in 2014, a slight increase was observed between 2015 and 2018, reaching 9.3/100 py (95% CI: 8.6-10.2) in 2019. Risk factors for MCI included younger age, lower educational level, having contracted HIV infection through injecting drug use or heterosexual intercourse, having been born outside of Spain, and CD4 count > 200 cell/μL, viral load <100,000 and co-infection with hepatitis C virus at enrolment.

CONCLUSIONS: Around a third of individuals had at least one MCI during the follow-up. Identified predictors of MCI can help health workers to target and support most vulnerable individuals.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app